As we head into 2023 with recession fears top of mind, here are a few of 蹤獲弝け News top predictions for what the new year has in store, based...
Health, Wellness & Biotech
The "omics" genomics, transcriptomics, metabolomics and proteomics are booming in biotech, with more big raises expected in 2023.
This year hasnt exactly been a blockbuster for the IPO markets. Venture funding has tanked and fewer startups have dared to step into the public...
We looked at 2021's six largest pre-IPO round recipients and how theyve fared since going public. To put it mildly, most underperformed expectations...
We here at 蹤獲弝け love to talk about billions billions in valuations, billions in revenue and billions in fundraising, even in a volatile year...
A lot happened in tech in 2022, much of it not particularly good. Bradley Tusk, co-founder and managing partner at Tusk Venture Partners, tackles the...
The sharp downturn in startup funding between 2021 and 2022 extends to venture-backed companies working on cancer therapies and diagnostics.
It was a weird week. Two of the top four rounds were actually large down rounds and a third came with restructuring and layoff news. Not exactly...
As we revisit a previously curated list of truly terrible SPAC performers, its clear theyre closing out the year at a particularly low point.
MasterControl, a decades old Salt Lake City-based company that provides software to manage the development of life science products, reached unicorn...
HistoSonics raised $85 million in funding led by Johnson & Johnson for a futuristic device it says could demolish tumors in patients with liver...


67.1K Followers